Ultimately, advancing our comprehension of SIRT6 could catalyze significant progress in the fight against pancreatic cancer, with the potential to improve outcomes for patients afflicted by this lethal disease. This evidence concerns the gene SIRT6 and familial pancreatic carcinoma.